How genetic variation affects patient response and outcome to therapy for psoriasis

被引:14
作者
Woolf, Richard T. [1 ]
Smith, Catherine H. [1 ]
机构
[1] Guys Hosp, St Johns Inst Dermatol, Div Genet & Mol Med, London SE1 9RT, England
关键词
biologics; methotrexate; pharmacogenetics; pharmacogenomics; psoriasis; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; D-RECEPTOR POLYMORPHISM; RHEUMATOID-ARTHRITIS; METHOTREXATE THERAPY; SUSCEPTIBILITY GENES; SYSTEMIC TREATMENTS; DOUBLE-BLIND; COAL-TAR;
D O I
10.1586/ECI.10.74
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriasis is a prevalent chronic inflammatory condition that affects the skin There are many treatments available for psoriasis but they are not universally effective and some have associated toxicities Pharmacogenetics and pharmacogenomics explore the relationship between individual genetic variation and drug effect to allow targeted personalized therapy for patients There has been very limited pharmacogenetic research regarding psoriasis with most limited to small retrospective case control studies looking at single-nucleotide polymorphisms in candidate genes involved in drug pharmacokinetics We review the pharmacogenetic investigation of treatments for psoriasis to date including emerging pharmacogenomic studies In addition we discuss how such genetic data could be incorporated into routine clinical practice and future areas for development in this field
引用
收藏
页码:957 / 966
页数:10
相关论文
共 84 条
[1]  
[Anonymous], 2009, Drug Ther Bull, V47, P9, DOI 10.1136/dtb.2008.12.0033
[2]   Guidelines for prescribing azathioprine in dermatology [J].
Anstey, AV ;
Wakelin, S ;
Reynolds, NJ .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (06) :1123-1132
[3]   Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis [J].
Asumalahti, K ;
Ameen, M ;
Suomela, S ;
Hagforsen, E ;
Michaëlsson, G ;
Evans, J ;
Munro, M ;
Veal, C ;
Allen, M ;
Leman, J ;
Burden, AD ;
Kirby, B ;
Connolly, M ;
Griffiths, CEM ;
Trembath, RC ;
Kere, J ;
Saarialho-Kere, U ;
Barker, JNWN .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (04) :627-632
[4]   Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted? [J].
Bansard, Carine ;
Lequerre, Thierry ;
Daveau, Maryvonne ;
Boyer, Olivier ;
Tron, Francois ;
Salier, Jean-Philippe ;
Vittecoq, Olivier ;
Le-Loet, Xavier .
RHEUMATOLOGY, 2009, 48 (09) :1021-1028
[5]   Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin [J].
Campalani, E ;
Allen, MH ;
Fairhurst, D ;
Young, HS ;
Mendonca, CO ;
Burden, AD ;
Griffiths, CEM ;
Crook, MA ;
Barker, JNWN ;
Smith, CH .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (02) :345-352
[6]   Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis [J].
Campalani, Emanuela ;
Arenas, Monica ;
Marinaki, Anthony M. ;
Lewis, Cathryn M. ;
Barker, Jonathan N. W. N. ;
Smith, Catherine H. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (08) :1860-1867
[7]   Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene [J].
Capon, Francesca ;
Bijlmakers, Marie-Jose ;
Wolf, Natalie ;
Quaranta, Maria ;
Huffmeier, Ulrike ;
Allen, Michael ;
Timms, Kirsten ;
Abkevich, Victor ;
Gutin, Alexander ;
Smith, Rhodri ;
Warren, Richard B. ;
Young, Helen S. ;
Worthington, Jane ;
Burden, A. David ;
Griffiths, Christopher E. M. ;
Hayday, Adrian ;
Nestle, Frank O. ;
Reis, Andre ;
Lanchbury, Jerry ;
Barker, Jonathan N. ;
Trembath, Richard C. .
HUMAN MOLECULAR GENETICS, 2008, 17 (13) :1938-1945
[8]   A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes [J].
Cargill, Michele ;
Schrodi, Steven J. ;
Chang, Monica ;
Garcia, Veronica E. ;
Brandon, Rhonda ;
Callis, Kristina P. ;
Matsunami, Nori ;
Ardlie, Kristin G. ;
Civello, Daniel ;
Catanese, Joseph J. ;
Leong, Diane U. ;
Panko, Jackie M. ;
McAllister, Linda B. ;
Hansen, Christopher B. ;
Papenfuss, Jason ;
Prescott, Stephen M. ;
White, Thomas J. ;
Leppert, Mark F. ;
Krueger, Gerald G. ;
Begovich, Ann B. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (02) :273-290
[9]   Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor α Therapy [J].
Cui, Jing ;
Saevarsdottir, Saedis ;
Thomson, Brian ;
Padyukov, Leonid ;
van der Helm-van Mil, Annette H. M. ;
Nititham, Joanne ;
Hughes, Laura B. ;
de Vries, Niek ;
Raychaudhuri, Soumya ;
Alfredsson, Lars ;
Askling, Johan ;
Wedren, Sara ;
Ding, Bo ;
Guiducci, Candace ;
Wolbink, Gert Jan ;
Crusius, J. Bart A. ;
van der Horst-Bruinsma, Irene E. ;
Herenius, Marieke ;
Weinblatt, Michael E. ;
Shadick, Nancy A. ;
Worthington, Jane ;
Batliwalla, Franak ;
Kern, Marlena ;
Morgan, Ann W. ;
Wilson, Anthony G. ;
Isaacs, John D. ;
Hyrich, Kimme ;
Seldin, Michael F. ;
Moreland, Larry W. ;
Behrens, Timothy W. ;
Allaart, Cornelia F. ;
Criswell, Lindsey A. ;
Huizinga, Tom W. J. ;
Tak, Paul P. ;
Bridges, S. Louis, Jr. ;
Toes, Rene E. M. ;
Barton, Anne ;
Klareskog, Lars ;
Gregersen, Peter K. ;
Karlson, Elizabeth W. ;
Plenge, Robert M. .
ARTHRITIS AND RHEUMATISM, 2010, 62 (07) :1849-1861
[10]   Genome-wide association studies in pharmacogenomics [J].
Daly, Ann K. .
NATURE REVIEWS GENETICS, 2010, 11 (04) :241-246